Medicine and Dentistry
Rehabilitation Engineering
100%
Patient with Asthma
100%
Dapagliflozin
100%
Lipid Metabolism
100%
Randomized Controlled Trial
100%
Pulmonary Rehabilitation
100%
Asthma
100%
Maturity Onset Diabetes of the Young
100%
Asthma Control Questionnaire
50%
Body Mass Index
50%
Exercise
50%
Placebo
33%
Glucagon
33%
Sodium Glucose Cotransporter 2 Inhibitor
33%
Patient with Type 2 Diabetes
33%
Fatty Acid
22%
3 Hydroxybutyric Acid
22%
Patient with Obesity
16%
Patient Care
16%
High Intensity Interval Training
16%
Care Group
16%
Nutritional Intervention
16%
Chylomicron Remnant
11%
Apolipoprotein B48
11%
Loading Test
11%
Ketone Bodies
11%
Triacylglycerol
11%
Cardiovascular System
11%
Fatty Acid Oxidation
11%
Lipoprotein
11%
Hyperlipidemia
11%
Keyphrases
Postprandial Lipid Metabolism
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Dapagliflozin
100%
Chemotherapy-induced Febrile Neutropenia
100%
Interconnected Data
100%
Docker Container
50%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
33%
Glucagon
33%
Type 2 Diabetic Patients
33%
Service Cloud
25%
Insulin
22%
β-hydroxybutyrate
22%
Placebo
22%
Glucose Level
22%
Postprandial Lipemia
22%
SMS Program
16%
Insulin Level
11%
Intensive Insulin Therapy
11%
Placebo-controlled
11%
Plasma Cholesterol
11%
Cardiovascular Mortality
11%
Plasma Triglycerides
11%
Postprandial Glucose
11%
Vascular Function
11%
Chylomicron Remnants
11%
Ketone Bodies
11%
Hepatic Fatty Acid Oxidation
11%
Lipoproteins
11%
Inflammatory Markers
11%
Load Test
11%
Postprandial Effect
11%
Free Fatty Acids
11%
Fatty Acids
11%
Clinical Effect
11%
Cardiovascular Morbidity
11%
Postprandial Response
11%
Insulin Dose
11%
Inflammation Markers
11%
Cardioprotection
11%
Postprandial Insulin
11%
Apolipoprotein B-48
11%
Lipid Metabolism
11%
Proof of Concept Study
11%
Fat Load
11%
Postprandial Inflammation
11%
Male Patients
11%
Pharmacology, Toxicology and Pharmaceutical Science
Dapagliflozin
100%
Non Insulin Dependent Diabetes Mellitus
100%
Sodium Glucose Cotransporter 2 Inhibitor
33%
Placebo
33%
Glucagon
33%
Fatty Acid
33%
Inflammation
22%
3 Hydroxybutyric Acid
22%
Chylomicron Remnant
11%
Triacylglycerol
11%
Apolipoprotein B48
11%
Lipoprotein
11%
Ketone Bodies
11%
Hyperlipidemia
11%
